All lobbying filings
CSL Behring LLC
CSL Behring LLC filed a Q3 amendment for CSL Behring LLC on October 30, 2026.
Lobbying for CSL Behring LLC
Filing · LD-2 quarterly report
Q3 amendment
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 30, 2026
Expenses
$480,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Pennsylvania
Government bodies contacted
2
Lobbying activity
3
HR 1476--Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act)--Medicare Part D phase-in of manufacturer liability; Issues related to Medicare Most Favored Nation
Issues related to corporate tax
Issues related to trade
Bills named in this filing
1